
Currently out of the existing stock ratings of Hartaj Singh, 200 are a BUY (97.09%), 6 are a HOLD (2.91%).
Analyst Hartaj Singh, has had 45.65% of price targets met with an average potential upside of 34.32%, reached in 285 days on average. Previously, Hartaj Singh worked at OPPENHEIMER, BTIG.
Hartaj Singh has documented 394 price targets and ratings displayed on 36 stocks. The coverage was on Healthcare, Industrials, Consumer Defensive sectors.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 05-May-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) on 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%), with a performance score of 77.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
5 years 6 months 16 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$156
5 years 6 months 18 days ago
(03-May-2021)
18/29 (62.07%)
$2.73 (1.60%)
667
Buy Since 08-Feb-2018
$166
$179
5 years 9 months 17 days ago
(04-Feb-2021)
21/21 (100%)
$10.41 (6.69%)
711
Hold Since 04-Feb-2021
$190
$194
5 years 9 months 17 days ago
(04-Feb-2021)
13/15 (86.67%)
$34.41 (22.12%)
458
Buy Since 06-Sep-2019
$175
$165
5 years 9 months 17 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Stocks Hartaj Singh covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.